Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes.

Oxid Med Cell Longev

Department of Biomedical and Specialist Surgical Sciences, Section of Medical Biochemistry, Molecular Biology and Genetics, University of Ferrara, Via Luigi Borsari 46, 44121 Ferrara, Italy.

Published: January 2019


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Paraoxonase-1 (PON1) and lipoprotein phospholipase A2 (Lp-PLA2) may exert an important protective role by preventing the oxidative transformation of high- and low-density lipoproteins (HDL and LDL, respectively). The activity of both enzymes is influenced by lipidome and proteome of the lipoprotein carriers. T2DM typically presents significant changes in the molecular composition of the lipoprotein subclasses. Thus, it becomes relevant to understand the interaction of PON1 and Lp-PLA2 with the subspecies of HDL, LDL, and other lipoproteins in T2DM. Serum levels of PON1-arylesterase and PON1-lactonase and Lp-PLA2 activities and lipoprotein subclasses were measured in 202 nondiabetic subjects (controls) and 92 T2DM outpatients. Arylesterase, but not lactonase or Lp-PLA2 activities, was inversely associated with TD2M after adjusting for potential confounding factors such as age, sex, smoking, body mass index, hypertension, and lipoprotein subclasses (odds ratio = 3.389, 95% confidence interval 1.069-14.756). Marked difference between controls and T2DM subjects emerged from the analyses of the associations of the three enzyme activities and lipoprotein subclasses. Arylesterase was independently related with large HDL-C and small intermediate-density lipoprotein cholesterol (IDL-C) in controls while, along with lactonase, it was related with small low-density lipoprotein cholesterol LDL-C, all IDL-C subspecies, and very low-density lipoprotein cholesterol (VLDL-C) in T2DM ( < 0.05 for all). Concerning Lp-PLA2, there were significant relationships with small LDL-C, large IDL-C, and VLDL-C only among T2DM subjects. Our study showed that T2DM subjects have lower levels of PON1-arylesterase compared to controls and that T2DM occurrence may coincide with a shift of PON1 and Lp-PLA2 towards the more proatherogenic lipoprotein subclasses. The possibility of a link between the two observed phenomena requires further investigations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247389PMC
http://dx.doi.org/10.1155/2018/1752940DOI Listing

Publication Analysis

Top Keywords

lipoprotein subclasses
24
lipoprotein
12
controls t2dm
12
t2dm subjects
12
lipoprotein cholesterol
12
lipoprotein phospholipase
8
phospholipase lp-pla2
8
hdl ldl
8
t2dm
8
pon1 lp-pla2
8

Similar Publications

Aim: To investigate the associations of intra-pancreatic fat deposition (IPFD) with low-density lipoprotein (LDL) subfractions and hepatic lipase.

Materials And Methods: IPFD was quantified using a single 3.0 Tesla magnetic resonance imaging scanner.

View Article and Find Full Text PDF

Metabolomics is a powerful molecular phenotyping technology which can be used in population studies to identify metabolites underlying disease conditions. To identify plasma biomarkers potentially predicting chronic diseases we applied H nuclear magnetic resonance (NMR) metabolomics using a 600 MHz spectrometer fitted with an In Vitro Diagnostics Research (IVDr) platform to test associations between 18 known metabolites and 111 lipoprotein constituents that could be quantified and passed our quality control procedure and 944 phenotypes determined in 302 healthy participants of the Japanese Nagahama Study. We identified 907 statistically significant associations (p < 4.

View Article and Find Full Text PDF

High-density lipoprotein in cardiovascular diseases: From high quantity to high quality.

Clin Chim Acta

August 2025

Department of Pathophysiology, Institute of Cardiovascular Disease, Key Lab for Arteriosclerology of Hunan Province, International Joint Laboratory for Arteriosclerotic Disease Research of Hunan Province, Hengyang Medical School, University of South China, Hengyang, China. Electronic address: huangj

High-density lipoprotein (HDL) plays a key role in reverse cholesterol transport (RCT), traditionally associated with cardiovascular protection. However, while low HDL-cholesterol (HDL-C) levels correlate with increased cardiovascular risk, therapeutic interventions raising HDL-C (e.g.

View Article and Find Full Text PDF

It is not known whether aerobic capacity (fitness) or overweight/obesity (fatness) moderate the association between physical activity (PA) and lipoproteins/lipids in children. The aim of this study was to investigate moderation of the cross-sectional and longitudinal associations between PA and the lipoprotein subclass profile by fitness and fatness in children. Eight hundred and sixty-two (cross-sectional analysis) or 787 (longitudinal analysis) children (age 10.

View Article and Find Full Text PDF

Plasma metabolomics uncovers key metabolites and enhances prediction of aortic stenosis: insights from prospective cohort and Mendelian randomisation studies.

Heart

August 2025

National Clinical Research Center for Kidney Disease, State Key Laboratory of Multi-organ Injury Prevention and Treatment, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China

Objective: To examine the association between nuclear magnetic resonance (NMR)-based metabolomics and aortic stenosis (AS) risk, and determine whether metabolomic profiling can enhance AS prediction beyond conventional clinical risk factors.

Methods: We included 168 metabolites in our study. The primary outcome of interest was incident AS.

View Article and Find Full Text PDF